Free Trial
→ Analyst nicknamed “The Prophet” issues new warning for America (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.82
+0.7%		$0.93
$0.76
▼
$16.68
$3.62M0.89837,658 shs93,482 shs
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$3.73
-3.6%		$6.21
$3.66
▼
$20.00
$12.19M1.3711,194 shs10,835 shs
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
$3.49
-6.2%		$3.31
$2.07
▼
$7.35
$16.39M-1.09173,409 shs209,114 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.90
+2.2%		$0.73
$0.61
▼
$1.65
$15.43M0.671.04 million shs706,170 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-0.07%-5.24%-2.68%-42.14%-90.54%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-2.27%-0.77%-44.73%-47.98%-79.53%
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
+16.61%-5.58%+24.83%-24.08%-42.08%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+29.41%+39.68%+25.71%-21.43%-20.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.82
+0.7%		$0.93
$0.76
▼
$16.68
$3.62M0.89837,658 shs93,482 shs
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$3.73
-3.6%		$6.21
$3.66
▼
$20.00
$12.19M1.3711,194 shs10,835 shs
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
$3.49
-6.2%		$3.31
$2.07
▼
$7.35
$16.39M-1.09173,409 shs209,114 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.90
+2.2%		$0.73
$0.61
▼
$1.65
$15.43M0.671.04 million shs706,170 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-0.07%-5.24%-2.68%-42.14%-90.54%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-2.27%-0.77%-44.73%-47.98%-79.53%
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
+16.61%-5.58%+24.83%-24.08%-42.08%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+29.41%+39.68%+25.71%-21.43%-20.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
1.00
SellN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
2.00
Hold$107.502,782.04% Upside
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
2.00
Hold$8.00129.23% Upside
IRIDEX Corporation stock logo
IRIX
IRIDEX
2.00
Hold$3.00234.08% Upside

Current Analyst Ratings Breakdown

Latest BJDX, ICU, IRIX, and CTSO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/2/2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/2/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
9/21/2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/18/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
9/4/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/21/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/6/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/17/2026
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
(Data available from 10/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/A$8.43 per shareN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$37.06M0.32N/AN/A$1.88 per share1.98
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
$1.23M12.51N/AN/A$2.75 per share1.27
IRIDEX Corporation stock logo
IRIX
IRIDEX
$52.67M0.30N/AN/A($0.06) per share-14.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$6.85M-$7.11N/AN/AN/AN/A-125.00%-99.79%11/13/2026 (Estimated)
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$8.20M-$5.80N/AN/AN/A-48.94%-431.65%-41.94%11/12/2026 (Estimated)
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
-$12.15M-$3.91N/AN/AN/A-795.51%-162.75%-109.89%11/12/2026 (Estimated)
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$4.44M-$0.20N/AN/AN/A-6.88%N/A-12.55%11/17/2026 (Estimated)

Latest BJDX, ICU, IRIX, and CTSO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/18/2026Q2 2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.01-$0.07-$0.06-$0.07$13.59 million$12.57 million
8/12/2026Q2 2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$3,520.00-$1.12+$3,518.88-$1.12N/AN/A
8/12/2026Q2 2026
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
-$0.97-$0.91+$0.06-$0.91$0.49 million$0.62 million
8/6/2026Q2 2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.80-$0.07+$0.73-$1.40$9.39 million$9.63 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
N/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
4.64
4.64
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
4.70
0.66
0.50
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
N/A
1.89
1.87
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/A
1.82
1.08

Institutional Ownership

CompanyInstitutional Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
1.69%
IRIDEX Corporation stock logo
IRIX
IRIDEX
20.10%

Insider Ownership

CompanyInsider Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
6.10%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
7.80%
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
0.70%
IRIDEX Corporation stock logo
IRIX
IRIDEX
8.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
64.47 million4.20 millionNot Optionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
1293.15 million2.91 millionOptionable
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
24.41 million4.38 millionNot Optionable
IRIDEX Corporation stock logo
IRIX
IRIDEX
10817.57 million16.05 millionOptionable

Recent News About These Companies

IRIDEX (NASDAQ:IRIX) Major Shareholder Buys 10,000 Shares of Company Stock
October 8 at 6:37 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-irix-insider-buying-and-selling-2026-10-08/
IRIDEX (NASDAQ:IRIX) Major Shareholder Acquires $20,800.00 in Stock
October 7 at 7:40 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31096050
IRIDEX (NASDAQ:IRIX) Major Shareholder Buys 50,000 Shares of Stock
October 7 at 7:10 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095826
IRIDEX (NASDAQ:IRIX) Major Shareholder Shih-Yao David Lin Acquires 15,000 Shares of Company Stock
October 7 at 7:10 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095824
IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Purchases 10,000 Shares
October 7 at 7:10 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095825
Insider Buying: IRIDEX (NASDAQ:IRIX) Major Shareholder Acquires 20,000 Shares of Stock
October 7 at 7:10 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095823
IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Acquires 20,000 Shares
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095822
IRIDEX (NASDAQ:IRIX) Major Shareholder Shih-Yao David Lin Acquires 11,404 Shares of Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095821
IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Purchases 11,773 Shares
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095820
IRIDEX (NASDAQ:IRIX) Major Shareholder Shih-Yao David Lin Buys 39,937 Shares of Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095818
Insider Buying: IRIDEX (NASDAQ:IRIX) Major Shareholder Purchases $58,000.00 in Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095814
IRIDEX (NASDAQ:IRIX) Major Shareholder Acquires 20,000 Shares of Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095815
IRIDEX (NASDAQ:IRIX) Major Shareholder Purchases $48,859.24 in Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095810
IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Purchases 40,114 Shares
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095817
IRIDEX (NASDAQ:IRIX) Major Shareholder Purchases 14,202 Shares of Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095816
Insider Buying: IRIDEX (NASDAQ:IRIX) Major Shareholder Acquires 10,000 Shares of Company Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095811
IRIDEX (NASDAQ:IRIX) Major Shareholder Shih-Yao David Lin Purchases 18,161 Shares of Company Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095803
IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Purchases 20,000 Shares
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095805
IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Acquires 24,626 Shares
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095806
Insider Buying: IRIDEX (NASDAQ:IRIX) Major Shareholder Purchases 20,000 Shares of Stock
October 7 at 7:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095807

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Micron, Coherent and Tower Semiconductor: 3 Stocks Built on AI's Bottlenecks
NVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In It
By Bridget Bennett | September 20, 2026
Stacks of coins rising on a desk beside a computer with an upward stock chart, with a blurred city skyline behind.
3 Dividend Kings to Buy While They’re Still Beaten Down
By Thomas Hughes | September 14, 2026
Stacks of US currency and an official document sit on a desk in a government chamber.
3 Stocks to Buy and Hold for Higher Interest Rates
By Thomas Hughes | September 9, 2026
Shopping bags sit on a polished marble floor inside an upscale retail store or shopping mall.
3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
By Nathan Reiff | September 16, 2026
An upward-trending chart arrow is overlaid on a cornfield with grain silos at sunset, symbolizing agricultural market growth.
3 Surging Stocks That Don’t Need the AI Boom to Keep Winning
By Nathan Reiff | September 21, 2026
Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$0.82 +0.01 (+0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$0.79 -0.03 (-3.26%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$3.73 -0.14 (-3.62%)
Closing price 04:00 PM Eastern
Extended Trading
$3.74 +0.02 (+0.40%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

SeaStar Medical stock logo

SeaStar Medical NASDAQ:ICU

$3.49 -0.23 (-6.18%)
Closing price 04:00 PM Eastern
Extended Trading
$3.53 +0.04 (+1.15%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$0.90 +0.02 (+2.24%)
Closing price 04:00 PM Eastern
Extended Trading
$0.89 -0.01 (-1.34%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas